Eagle Health Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Eagle Health Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Buy	+194,577	New	+$14.6M	2.56%	18

Other funds holding IONS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Eagle Health Investments's IONS Position: Q2 2026 in Review

Eagle Health Investments opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 194,577 shares worth $15.4M. The stake represents 2.56% of the portfolio and ranks #18 among its holdings.

235 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Eagle Health Investments held 194,577 shares of Ionis Pharmaceuticals worth $15.4M as of Q2 2026.
Ionis Pharmaceuticals was a new Eagle Health Investments position in Q2 2026.
Ionis Pharmaceuticals made up 2.56% of Eagle Health Investments's portfolio in Q2 2026, its #18 holding.
235 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.